TORONTO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free ...
Some results have been hidden because they may be inaccessible to you